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The Integration of Vascular Biology and Vascular
Disease Diagnosis and InterventionThis journal always has published a few vascular biology
papers. There has been hot debate at the Editorial Board as
to whether this tradition should continue. The most
important reason to continue this tradition is because
advances in vascular biology and advances in the diagnosis
and management of arterial disease are not independent.
Some of the strongest evidence to support this latter
statement comes from the field of functional imaging.
In this issue of the journal there is a focus on functional
vascular imaging, with a group of 3 papers presented either
orally or as a poster at the ESVS meeting in Nice.1e3 To
enable all readers to appreciate the context and contri-
bution of these papers, they are prefaced by an invited
overview.4
Two of the original contributions have used positron
emission tomography (PET) to image 18F-fluorodeox-
yglucose (FDG) uptake to identify areas of increased
metabolic activity.1,2 Graebe et al.1 have taken the
opportunity, unique to vascular surgeons, to correlate the
PET scanning observations with gene expression in carotid
endarterectomy specimens. Their results provide strong
evidence that PET scanning reflects the presence of acti-
vated macrophages in the diseased carotid artery. Kotze
et al.2 have studied abdominal aortic aneurysms, showing
again that FDG uptake is highest in inflammatory aneu-
rysms. However significant FDG uptake was present in all 14
aneurysms studied, even the small aneurysms. The extent
of FDG uptake was not correlated with aneurysm diameter,
suggesting the importance of inflammation in all stages of
abdominal aortic aneurysm development.
The final original paper, Giannoni et al.3 used contrast
ultrasonography to image the neoangiogenesis in carotid
plaques: stenoses in patients who had experiences of focal
neurological symptoms within the last week were associ-
ated with increased neoangiogenesis at the base of the
plaque. This field of research needs to be extended, to
correlate the uptake of microbubble contrast with protein
markers of neoangiogenesis and changes in gene expression
in the areas affected by neoangiogenesis in endarterectomy
specimens. In addition, there is the potential to use1078-5884/$36 ª 2009 European Society for Vascular Surgery. Publishe
doi:10.1016/j.ejvs.2009.01.025microbubbles coated with antibodies or other protein
ligands, to explore in detail the biology of the diseased
vessel wall. This is a field wide open for important research
in which those engaged in vascular imaging and interven-
tion should play a major role.
This journal would welcome more submissions in this
and all other areas of functional vascular imaging. There
are other areas too where vascular biology is of great
importance to vascular disease, imaging and intervention.
Traditionally these have revolved around the use of animal
models of human diseases, which continue to become more
sophisticated with advances in transgenic techniques.
Furthermore the advances in screening technologies, such
as microarrays, multiplex genotyping and proteomics,
promise to drive an explosive increase in our understanding
of vascular pathology. There also is interest in treating
vascular diseases with novel strategies such as stem cells
and other agents, which might stimulate either arterio-
genesis or increased blood flow around occlusive arterial
lesions. Reviews on these topics are scheduled during the
coming 2 years and we are actively seeking original
manuscripts to accompany them, so that, as in this issue,
we can focus on a particular group of techniques or topics
in depth.
Currently much of vascular diagnosis and management
is driven by dividing patients into large disease or symptom
categories (e.g. intermittent claudication, 70% carotid
stenosis). Application of the information from new
vascular biology studies, along with newer imaging tech-
niques as discussed in the current issue, may allow more
selective diagnosis and management of vascular disease,
tailored to individual patients. We aim to keep readers
abreast with important scientific advances and show how
top quality vascular biology is important for all readers of
this journal.
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